American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

被引:471
作者
Perrillo, Robert P. [1 ]
Gish, Robert [2 ,3 ]
Falck-Ytter, Yngve T. [4 ]
机构
[1] Univ Texas Southwestern, Baylor Univ, Med Ctr, Hepatol Div,Dept Med, Dallas, TX USA
[2] Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA
[3] Hepatitis B Fdn, Doylestown, PA USA
[4] Case Western Reserve Univ, Dept Med, Div Gastroenterol & Hepatol, Case & VA Med Ctr, Cleveland, OH 44106 USA
关键词
INFLAMMATORY-BOWEL-DISEASE; CHRONIC ACTIVE HEPATITIS; ARTERIAL CHEMOEMBOLIZATION THERAPY; RECEIVING CYTOTOXIC CHEMOTHERAPY; TASK-FORCE RECOMMENDATION; DOSE METHOTREXATE THERAPY; HBSAG-NEGATIVE PATIENTS; BREAST-CANCER PATIENTS; NON-HODGKINS-LYMPHOMA; HBV REACTIVATION;
D O I
10.1053/j.gastro.2014.10.038
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:221 / U378
页数:27
相关论文
共 104 条
[1]   Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management [J].
Abramson, Amanda ;
Menter, Alan ;
Perrillo, Robert .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) :1349-1361
[2]   Patients with Inflammatory Bowel Disease Have a Lower Response Rate to HBV Vaccination Compared to Controls [J].
Altunoz, Mustafa Erhan ;
Senates, Ebubekir ;
Yesil, Atakan ;
Calhan, Turan ;
Ovunc, Ayse Oya Kurdas .
DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) :1039-1044
[3]  
[Anonymous], 2014, OPENMETAANALYST VERS
[4]  
[Anonymous], 2012, REV MANAGER REVMAN C
[5]   American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases [J].
Artz, Andrew S. ;
Somerfield, Mark R. ;
Feld, Jordan J. ;
Giusti, Andrew F. ;
Kramer, Barnett S. ;
Sabichi, Anita L. ;
Zon, Robin T. ;
Wong, Sandra L. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) :3199-3202
[6]   Safety of Tumor Necrosis Factor α Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative/Anti-Hepatitis B Core Antigen Positive) With Rheumatic Diseases [J].
Caporali, R. ;
Bobbio-Pallavicini, F. ;
Atzeni, F. ;
Sakellariou, G. ;
Caprioli, M. ;
Montecucco, C. ;
Sarzi-Puttini, P. .
ARTHRITIS CARE & RESEARCH, 2010, 62 (06) :749-754
[7]   Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action [J].
Carroll, Matthew B. ;
Forgione, Michael A. .
CLINICAL RHEUMATOLOGY, 2010, 29 (09) :1021-1029
[8]   Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B [J].
Chang, Ting-Tsung ;
Lai, Ching-Lung ;
Yoon, Seung Kew ;
Lee, Samuel S. ;
Coelho, Henrique Sergio M. ;
Carrilho, Flair Jose ;
Poordad, Fred ;
Halota, Waldemar ;
Horsmans, Yves ;
Tsai, Naoky ;
Zhang, Hui ;
Tenney, Daniel J. ;
Tamez, Ricardo ;
Iloeje, Uchenna .
HEPATOLOGY, 2010, 51 (02) :422-430
[9]   A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B [J].
Chang, TT ;
Gish, RG ;
de Man, R ;
Gadano, A ;
Sollano, J ;
Chao, YC ;
Lok, AS ;
Han, KH ;
Goodman, Z ;
Zhu, J ;
Cross, A ;
DeHertogh, D ;
Wilber, R ;
Colonno, R ;
Apelian, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1001-1010
[10]   Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients [J].
Charpin, Caroline ;
Guis, Sandrine ;
Colson, Philippe ;
Borentain, Patrick ;
Mattei, Jean-Pierre ;
Alcaraz, Patrice ;
Balandraud, Nathalie ;
Thomachot, Benoit ;
Roudier, Jean ;
Gerolami, Rene .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)